Ignite Creation Date:
2024-05-05 @ 11:37 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00090402
Status:
COMPLETED
Last Update Posted:
2017-07-21
First Post:
2004-08-25
Brief Title:
Fish Oil and Alpha Lipoic Acid in Treating Alzheimers Disease
Sponsor:
Oregon Health and Science University
Organization:
Oregon Health and Science University
Study Overview
Official Title:
Fish Oil and Alpha Lipoic Acid in Mild Alzheimers Disease
Status:
COMPLETED
Status Verified Date:
2017-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine the effect of fish oil and the antioxidant alpha lipoic acid on factors in the blood that are associated with the progression of Alzheimers Disease AD
Detailed Description:
Alzheimers disease AD is a serious condition associated with increased inflammation cholesterol and oxidative stress a condition involving an excess of free radicals and a decrease in antioxidant levels Fish oil and alpha lipoic acid which have few side effects may help relieve these problems therefore these supplements may slow the progression of AD particularly when given in combination This study will evaluate the effect of fish oil and alpha lipoic acid on inflammation lipid levels and oxidative stress
Participants in this study will be randomly assigned to receive fish oil alone fish oil and alpha lipoic acid or placebo for 1 year AD rating scales as well as urine and blood tests will be used to assess participants Participants will have monthly clinic visits during the study to monitor adverse events and to undergo various laboratory tests
Participants in this study will be randomly assigned to receive fish oil alone fish oil and alpha lipoic acid or placebo for 1 year AD rating scales as well as urine and blood tests will be used to assess participants Participants will have monthly clinic visits during the study to monitor adverse events and to undergo various laboratory tests
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 1R21AG023805-01 | NIH | None | None |
| 5R21AG023805-02 | NIH | None | None |
| AG08017 | OTHER_GRANT | None | None |
| M01RR000334 | NIH | National Institute of Aging | httpsreporternihgovquickSearchM01RR000334 |